普通股股本 更改
AstraZeneca USD 1.55B 44K 2026-06
Genmab DKK 61.44M 181K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
GRIFOLS EUR 680.58M 6K 2026-06
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lakefront Biotherapeutics EUR 65.66M 242K 2026-06
Qiagen NV USD 206.5M 245K 2026-06
UCB EUR 190.36M 365.15K 2025-12